Annual Cash & Cash Equivalents
$190.00 K
-$167.00 K-46.78%
December 31, 2023
Summary
- As of February 7, 2025, BSGM annual cash & cash equivalents is $190.00 thousand, with the most recent change of -$167.00 thousand (-46.78%) on December 31, 2023.
- During the last 3 years, BSGM annual cash & cash equivalents has fallen by -$28.08 million (-99.33%).
- BSGM annual cash & cash equivalents is now -99.33% below its all-time high of $28.27 million, reached on December 31, 2020.
Performance
BSGM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$615.00 K
-$1.49 M-70.77%
September 30, 2024
Summary
- As of February 7, 2025, BSGM quarterly cash and cash equivalents is $615.00 thousand, with the most recent change of -$1.49 million (-70.77%) on September 30, 2024.
- Over the past year, BSGM quarterly cash and cash equivalents has increased by +$425.00 thousand (+223.68%).
- BSGM quarterly cash and cash equivalents is now -98.33% below its all-time high of $36.93 million, reached on June 30, 2020.
Performance
BSGM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BSGM Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -46.8% | +223.7% |
3 y3 years | -99.3% | +72.3% |
5 y5 years | -95.7% | +72.3% |
BSGM Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -98.4% | at low | -94.7% | +223.7% |
5 y | 5-year | -99.3% | at low | -98.3% | +223.7% |
alltime | all time | -99.3% | at low | -98.3% | +1357.3% |
BioSig Technologies Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $615.00 K(-70.8%) |
Jun 2024 | - | $2.10 M(+405.8%) |
Mar 2024 | - | $416.00 K(+118.9%) |
Dec 2023 | $190.00 K(-46.8%) | $190.00 K(-51.2%) |
Sep 2023 | - | $389.00 K(-68.9%) |
Jun 2023 | - | $1.25 M(-11.3%) |
Mar 2023 | - | $1.41 M(+295.5%) |
Dec 2022 | $357.00 K(-96.9%) | $357.00 K(-59.8%) |
Sep 2022 | - | $887.00 K(-82.5%) |
Jun 2022 | - | $5.08 M(-41.4%) |
Mar 2022 | - | $8.66 M(-25.7%) |
Dec 2021 | $11.66 M(-58.8%) | $11.66 M(-33.5%) |
Sep 2021 | - | $17.54 M(+13.1%) |
Jun 2021 | - | $15.50 M(-31.0%) |
Mar 2021 | - | $22.48 M(-20.5%) |
Dec 2020 | $28.27 M(+133.4%) | $28.27 M(-13.7%) |
Sep 2020 | - | $32.75 M(-11.3%) |
Jun 2020 | - | $36.93 M(+138.2%) |
Mar 2020 | - | $15.50 M(+28.0%) |
Dec 2019 | $12.11 M | $12.11 M(-1.6%) |
Sep 2019 | - | $12.31 M(+19.1%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2019 | - | $10.33 M(-5.5%) |
Mar 2019 | - | $10.93 M(+145.7%) |
Dec 2018 | $4.45 M(+187.6%) | $4.45 M(-38.9%) |
Sep 2018 | - | $7.28 M(+98.2%) |
Jun 2018 | - | $3.67 M(+254.9%) |
Mar 2018 | - | $1.04 M(-33.1%) |
Dec 2017 | $1.55 M(+46.6%) | $1.55 M(+560.5%) |
Sep 2017 | - | $234.30 K(-73.4%) |
Jun 2017 | - | $880.70 K(-29.2%) |
Mar 2017 | - | $1.24 M(+17.8%) |
Dec 2016 | $1.06 M(+10.8%) | $1.06 M(+601.6%) |
Sep 2016 | - | $150.50 K(-78.7%) |
Jun 2016 | - | $705.30 K(+412.6%) |
Mar 2016 | - | $137.60 K(-85.6%) |
Dec 2015 | $953.20 K(+297.5%) | $953.20 K(+184.9%) |
Sep 2015 | - | $334.60 K(-72.1%) |
Jun 2015 | - | $1.20 M(-41.9%) |
Mar 2015 | - | $2.06 M(+758.8%) |
Dec 2014 | $239.80 K(-20.6%) | $239.80 K(-10.8%) |
Sep 2014 | - | $268.90 K(+537.2%) |
Jun 2014 | - | $42.20 K(-86.0%) |
Dec 2013 | $302.20 K | $302.20 K |
FAQ
- What is BioSig Technologies annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for BioSig Technologies?
- What is BioSig Technologies annual cash & cash equivalents year-on-year change?
- What is BioSig Technologies quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for BioSig Technologies?
- What is BioSig Technologies quarterly cash and cash equivalents year-on-year change?
What is BioSig Technologies annual cash & cash equivalents?
The current annual cash & cash equivalents of BSGM is $190.00 K
What is the all time high annual cash & cash equivalents for BioSig Technologies?
BioSig Technologies all-time high annual cash & cash equivalents is $28.27 M
What is BioSig Technologies annual cash & cash equivalents year-on-year change?
Over the past year, BSGM annual cash & cash equivalents has changed by -$167.00 K (-46.78%)
What is BioSig Technologies quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BSGM is $615.00 K
What is the all time high quarterly cash and cash equivalents for BioSig Technologies?
BioSig Technologies all-time high quarterly cash and cash equivalents is $36.93 M
What is BioSig Technologies quarterly cash and cash equivalents year-on-year change?
Over the past year, BSGM quarterly cash and cash equivalents has changed by +$425.00 K (+223.68%)